Cargando…
Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236121/ https://www.ncbi.nlm.nih.gov/pubmed/34185404 http://dx.doi.org/10.1002/ctm2.456 |
| _version_ | 1783714472698839040 |
|---|---|
| author | Zhang, Zhihui Zhang, Chaoqi Zhang, Guochao Luo, Yuejun Xue, Liyan Zeng, Qingpeng Wu, Peng Wang, Lide Sun, Nan He, Jie |
| author_facet | Zhang, Zhihui Zhang, Chaoqi Zhang, Guochao Luo, Yuejun Xue, Liyan Zeng, Qingpeng Wu, Peng Wang, Lide Sun, Nan He, Jie |
| author_sort | Zhang, Zhihui |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8236121 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82361212021-06-29 Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma Zhang, Zhihui Zhang, Chaoqi Zhang, Guochao Luo, Yuejun Xue, Liyan Zeng, Qingpeng Wu, Peng Wang, Lide Sun, Nan He, Jie Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-06-27 /pmc/articles/PMC8236121/ /pubmed/34185404 http://dx.doi.org/10.1002/ctm2.456 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Zhang, Zhihui Zhang, Chaoqi Zhang, Guochao Luo, Yuejun Xue, Liyan Zeng, Qingpeng Wu, Peng Wang, Lide Sun, Nan He, Jie Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma |
| title | Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma |
| title_full | Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma |
| title_fullStr | Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma |
| title_full_unstemmed | Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma |
| title_short | Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma |
| title_sort | tumor‐infiltrating cd8(+) t cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236121/ https://www.ncbi.nlm.nih.gov/pubmed/34185404 http://dx.doi.org/10.1002/ctm2.456 |
| work_keys_str_mv | AT zhangzhihui tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT zhangchaoqi tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT zhangguochao tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT luoyuejun tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT xueliyan tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT zengqingpeng tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT wupeng tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT wanglide tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT sunnan tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma AT hejie tumorinfiltratingcd8tcellisprognosticandpredictsadjuvantchemotherapybenefitinpatientswithlimitedstagesmallcellesophagealcarcinoma |